Research programme: Gut receptor agonists - Kallyope
Latest Information Update: 23 Jun 2023
At a glance
- Originator Kallyope
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Metabolic disorders
Most Recent Events
- 18 May 2023 Early research in Metabolic disorders in USA (PO) (Kallyope pipeline, May 2023)